Tudor Investment Corp’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.4K | Sell |
12,073
-21,355
| -64% | -$137K | ﹤0.01% | 1482 |
|
|
2025
Q1 | $118K | Sell |
33,428
-259
| -0.8% | -$917 | ﹤0.01% | 1434 |
|
|
2024
Q4 | $127K | Buy |
+33,687
| New | +$127K | ﹤0.01% | 1430 |
|
|
2024
Q2 | – | Sell |
-12,753
| Closed | -$36.2K | – | 1484 |
|
|
2024
Q1 | $36.2K | Sell |
12,753
-20,899
| -62% | -$59.4K | ﹤0.01% | 1393 |
|
|
2023
Q4 | $495K | Buy |
33,652
+6,293
| +23% | +$92.6K | ﹤0.01% | 1138 |
|
|
2023
Q3 | $501K | Sell |
27,359
-32,256
| -54% | -$591K | 0.01% | 1119 |
|
|
2023
Q2 | $1.29M | Buy |
59,615
+22,051
| +59% | +$476K | 0.02% | 813 |
|
|
2023
Q1 | $1.1M | Buy |
37,564
+1,567
| +4% | +$46K | 0.02% | 871 |
|
|
2022
Q4 | $1.33M | Buy |
35,997
+19,859
| +123% | +$734K | 0.03% | 720 |
|
|
2022
Q3 | $454K | Buy |
+16,138
| New | +$454K | 0.01% | 1138 |
|